Methyl 5-[[5-amino-1-[6-[5-amino-4-[(4-methoxycarbonyl-3-methyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-3-methyl-1H-pyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1-phenylpyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-phenylpyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1H-pyrazole-4-carboxylate
C78H76N50O14 — CID 158882688
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 5-[[5-amino-1-[6-[5-amino-4-[(4-methoxycarbonyl-3-methyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-3-methyl-1H-pyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1-phenylpyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-phenylpyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1H-pyrazole-4-carboxylate
Methyl 5-[[5-amino-1-[6-[5-amino-4-[(4-methoxycarbonyl-3-methyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-3-methyl-1H-pyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1-phenylpyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-phenylpyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1H-pyrazole-4-carboxylate (PubChem CID 158882688) has the molecular formula C78H76N50O14 and a molecular weight of 1937.80 g/mol. Its IUPAC name is methyl 5-[[5-amino-1-[6-[5-amino-4-[(4-methoxycarbonyl-3-methyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-3-methyl-1H-pyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1-phenylpyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-phenylpyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1H-pyrazole-4-carboxylate.
Molecular Properties
| Compound Name | Methyl 5-[[5-amino-1-[6-[5-amino-4-[(4-methoxycarbonyl-3-methyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-3-methyl-1H-pyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1-phenylpyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-phenylpyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1H-pyrazole-4-carboxylate |
|---|---|
| PubChem CID | 158882688 |
| Molecular Formula | C78H76N50O14 |
| Molecular Weight | 1937.80 g/mol |
| Exact Mass | 1936.68 |
| IUPAC Name | methyl 5-[[5-amino-1-[6-[5-amino-4-[(4-methoxycarbonyl-3-methyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]pyrimidin-4-yl]-3-methylpyrazol-4-yl]diazenyl]-3-methyl-1H-pyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1-phenylpyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1-phenylpyrazole-4-carboxylate;methyl 5-[[5-amino-1-[4-[5-amino-4-[(4-methoxycarbonyl-1H-pyrazol-5-yl)diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-1H-pyrazole-4-carboxylate |
| SMILES | COC(=O)c1c(C)n[nH]c1/N=N/c1c(C)nn(-c2cc(-n3nc(C)c(/N=N/c4[nH]nc(C)c4C(=O)OC)c3N)ncn2)c1N.COC(=O)c1cn[nH]c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4[nH]ncc4C(=O)OC)c3N)n2)c1N.COC(=O)c1cnn(-c2ccccc2)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C(=O)OC)cnn4-c4ccccc4)c3N)n2)c1N |
| InChI | InChI=1S/C33H29N17O5.C24H26N16O4.C21H21N17O5/c1-17-23(41-43-27-21(29(51)54-3)15-36-47(27)19-11-7-5-8-12-19)25(34)49(45-17)31-38-32(40-33(53)39-31)50-26(35)24(18(2)46-50)42-44-28-22(30(52)55-4)16-37-48(28)20-13-9-6-10-14-20;1-9-15(23(41)43-5)21(33-29-9)35-31-17-11(3)37-39(19(17)25)13-7-14(28-8-27-13)40-20(26)18(12(4)38-40)32-36-22-16(24(42)44-6)10(2)30-34-22;1-7-11(29-33-15-9(5-24-31-15)17(39)42-3)13(22)37(35-7)19-26-20(28-21(41)27-19)38-14(23)12(8(2)36-38)30-34-16-10(6-25-32-16)18(40)43-4/h5-16H,34-35H2,1-4H3,(H,38,39,40,53);7-8H,25-26H2,1-6H3,(H,29,33)(H,30,34);5-6H,22-23H2,1-4H3,(H,24,31)(H,25,32)(H,26,27,28,41)/b43-41+,44-42+;35-31+,36-32+;33-29+,34-30+ |
| InChIKey | JDFMXHDZYGMILI-ZXKCHPGSSA-N |
| XLogP | 9.18 |
| TPSA | 863.10 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 60 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 142 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1937.80 |
| LogP ≤ 5 | 9.18 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 60 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158882688 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.